The Venture Codex Logo

The Venture Codex

Ajinomoto

15-1 Kyobashi 1-chome, Chuo-ku, Tokyo, 104-8315, Japan

Overview

Global manufacturer of seasonings, processed foods, and amino acids.

Founded

1925

Deals ยท 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

Canada
Japan
United Kingdom
United States

Sector focus

Agriculture
Food and Beverage
Food Processing
Manufacturing

Investment portfolio

7rounds
NAMEDATESIZE
Restore Vision
Apr 2026Participated
$8 MSeries B
Enhanced Medical Nutrition
Jan 2025Led
$5 MSeries A
Safire Technology Group
Sep 2024Participated
$8 MSeries A
TechMagic
Mar 2024Participated
$17 MSeries C
Ascend Gene & Cell Therapies
May 2023Participated
$133 MSeries A
DAIZ
Apr 2021Participated
$17 MSeries B
MycoTechnology
Oct 2017Participated
$42 MSeries B
Restore Vision
Apr 2026Participated
$8 MSeries B
Enhanced Medical Nutrition
Jan 2025Led
$5 MSeries A
Safire Technology Group
Sep 2024Participated
$8 MSeries A
TechMagic
Mar 2024Participated
$17 MSeries C
Ascend Gene & Cell Therapies
May 2023Participated
$133 MSeries A
DAIZ
Apr 2021Participated
$17 MSeries B
MycoTechnology
Oct 2017Participated
$42 MSeries B
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Ajinomoto: 7 funding rounds are recorded in the selected participation categories.All available history.
Ajinomoto: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A12
Series B03
Series C+01

Monthly Deal Activity

Ajinomoto: 7 deals are recorded across 109 months.All available history.
Ajinomoto: 7 deals are recorded across 109 months. All available history
MonthDeals
Oct '171
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '211
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '241
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Ajinomoto: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Ajinomoto: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
Food & Agriculture3
Hardware & Robotics2
Professional Services2
Manufacturing1
AI & Machine Learning1
Clean Energy & Sustainability1
Space & Frontier Tech1

Deal Size Distribution

Ajinomoto: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Ajinomoto: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M3
$10M-$25M2
$25M-$50M1
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Ajinomoto: Japan has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Ajinomoto: Japan has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
Japan3
United States2
Canada1
Europe1
Ajinomoto: 20 co-investors are shown, with 4BIO Capital sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Ajinomoto: 20 co-investors are shown, with 4BIO Capital sharing 1 recorded deals. All available history
Co-investorShared deals
4BIO Capital1
Abingworth1
Astellas Venture Management1
Automotive Ventures1
Canaan Partners1
Cathay Capital1
Continental Grain Company1
Correlation Ventures1
DCVC Bio1
Deerfield Management1
Digitalis Ventures1
DSM Venturing1
Elder Ventures1
ENEOS Innovation Partners1
Global Brain1
Golden Asia Fund II1
Health for Life Capital1
HL Ventures1
Japan Science and Technology Agency1
Japan Venture Capital1

Investment Strategy

Ajinomoto: Led accounts for 14% and participating for 86% of round participation.All available history.
Ajinomoto: Led accounts for 14% and participating for 86% of round participation. All available history
CategoryDeals (count)Share (%)
Led114%
Participating686%
Ajinomoto: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Ajinomoto: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Hiromichi Ono

Corporate Vice President

Hiroshi Fukushi

Corporate Senior Vice President & General Manager, AminoScience Division

Koji Igarashi

Corporate Senior Vice President

Makoto Murabayashi

Corporate Vice President

Masatoshi Ito

Representative Director

Masaya Tochio

Corporate Vice President

Takaaki Nishii

Representative Director, President & Chief Executive Officer

Yoichiro Togashi

Standing Corporate Auditor